Halozyme Therapeutics shares owned by Natixis
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Natixis
from 13F filings
Historical chart of Natixis investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Natixis
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.2M | 126k | 73.34 |
| 2025-03-31 | $435k | 6.9k | 63.35 |
| 2024-12-31 | $9.9k | 207 | 47.81 |
| 2024-09-30 | $12k | 207 | 57.24 |
| 2024-06-30 | $10k | 194 | 52.36 |
| 2024-03-31 | $7.9k | 194 | 40.68 |
| 2022-12-31 | $9.6M | 168k | 56.90 |
| 2022-09-30 | $1.5M | 38k | 39.55 |
| 2022-06-30 | $3.0M | 68k | 44.01 |
| 2021-12-31 | $830k | 21k | 40.20 |
| 2021-09-30 | $2.1M | 51k | 40.68 |
| 2021-06-30 | $617k | 14k | 45.42 |
| 2021-03-31 | $1.5M | 37k | 41.68 |
| 2020-12-31 | $21M | 486k | 42.71 |